Purpuric Skin Rash in a Patient Undergoing Pfizer-BioNTech COVID-19 Vaccination: Histological Evaluation and Perspectives

Purpuric Skin Rash in a Patient Undergoing Pfizer-BioNTech COVID-19 Vaccination: Histological Evaluation and Perspectives

The COVID-19 pandemic has affected the entire planet, and within about a year and a half, has led to 174,502,686 confirmed cases of COVID-19 worldwide, with 3,770,361 deaths. Although it is now clear that SARS-CoV-2 can affect various different organs, including the lungs, brain, skin, vessels, plac...

Full description

Bibliographic Details
Main Authors: Gerardo Cazzato, Paolo Romita, Caterina Foti, Antonietta Cimmino, Anna Colagrande, Francesca Arezzo, Sara Sablone, Angela Barile, Teresa Lettini, Leonardo Resta, Giuseppe Ingravallo
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Vaccines
Subjects:
SARS-CoV-2
COVID-19
skin
rash
purpuric
vaccines
Online Access:https://www.mdpi.com/2076-393X/9/7/760

Internet

https://www.mdpi.com/2076-393X/9/7/760

Similar Items